Corrigendum: The possible effectiveness of difamilast in improving barrier dysfunction in patients with atopic dermatitis and in mouse model

Lignende værker

• Corrigendum: The possible effectiveness of difamilast in improving barrier dysfunction in patients with atopic dermatitis and in mouse model
  af: Akihiko Uchiyama, et al.
  Udgivet: (2026-02-01)
• Matching-Adjusted Indirect Comparison of the Efficacy and Safety of Difamilast 1% and Delgocitinib 0.5% in Patients with Moderate-to-Severe Atopic Dermatitis
  af: Takeshi Nakahara, et al.
  Udgivet: (2024-10-01)
• Cost-Effectiveness Study of Difamilast 1% for the Treatment of Atopic Dermatitis in Adult Japanese Patients
  af: Takeshi Nakahara, et al.
  Udgivet: (2024-11-01)
• A Phase 3, Long-Term, Open-Label Study of Difamilast Ointment to Evaluate Efficacy and Safety in Japanese Infants with Atopic Dermatitis
  af: Hidehisa Saeki, et al.
  Udgivet: (2025-10-01)
• An Interim Report of a Phase 3, Long-Term, Open-Label Study to Evaluate Efficacy and Safety of Difamilast Ointment in Japanese Infants with Atopic Dermatitis
  af: Hidehisa Saeki, et al.
  Udgivet: (2024-07-01)